Hua Yan

Tianjin Huanhu Hospital — China

Medicine · Health Sciences

16h-index1.8kcitations41works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(7), Acute Myeloid Leukemia Research(6), Retinoids in leukemia and cellular processes(5), Nanocomposite Films for Food Packaging(4), RNA modifications and cancer(3)

Publications41 total

Comparative efficacy of cisternal drainage versus external ventricular drainage in severe aneurysmal subarachnoid hemorrhage
PLoS ONE·2026Open Access
When the heart chokes itself: coronary occlusion in infective endocarditis
European Heart Journal·2025
Targeting the HuR/E2F7 axis synergizes with bortezomib against multiple myeloma
Acta Pharmacologica Sinica·2025· 2 citedOpen Access
1α,25(OH)2D3 Alleviates Exhaustion and Promotes Antitumor Function of Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells in DLBCL
Blood·2024Open Access
Indisulam synergizes with melphalan to inhibit Multiple Myeloma malignancy via targeting TOP2A
PLoS ONE·2024· 2 citedOpen Access
Association of serum 25-hydroxyvitamin D concentrations and myopia in the U.S. Population — Results from the NHANES 2001-2008
Nutrición Hospitalaria·2024Open Access
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: a retrospective multicenter study from China
BMC Cancer·2023· 6 citedOpen Access
Outcome and characteristics of nonsecretory multiple myeloma compared with secretory multiple myeloma: A retrospective multicenter study from China
Research Square (Research Square)·2022Open Access
Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
Clinical Lymphoma Myeloma & Leukemia·2019· 4 cited
Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy
Haematologica·2019· 66 citedOpen Access
Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells
Life Sciences·2019· 32 cited
Discriminating Depth of Response to Therapy in Multiple Myeloma Using Whole-body Diffusion-weighted MRI with Apparent Diffusion Coefficient
Academic Radiology·2018· 38 citedOpen Access
Effective Treatment of Relapsed/Refractory Multiple Myeloma by Bi-Epitope BCMA-Specific Chimeric Antigen Receptor-Modified T Cells
SSRN Electronic Journal·2018Open Access
ShenFu Preparation Protects AML12 Cells Against Palmitic Acid-Induced Injury Through Inhibition of Both JNK/Nox4 and JNK/NFκB Pathways
Cellular Physiology and Biochemistry·2018· 15 citedOpen Access
Preparation and characterization of antioxidant edible chitosan films incorporated with epigallocatechin gallate nanocapsules
Carbohydrate Polymers·2017· 108 cited
Applications of chitosan nanoparticles to enhance absorption and bioavailability of tea polyphenols: A review
Food Hydrocolloids·2017· 295 cited
Encapsulation of epigallocatechin gallate in zein/chitosan nanoparticles for controlled applications in food systems
Food Chemistry·2017· 193 cited
Synthesis and controlled-release properties of chitosan/β-Lactoglobulin nanoparticles as carriers for oral administration of epigallocatechin gallate
Food Science and Biotechnology·2016· 51 citedOpen Access
Recent progress in the preparation of aniline copolymer and its properties
2016
Novel agent induction therapy alone or followed by autologous stem cell transplantation in younger patients with multiple myeloma: A single-center retrospective study of 114 cases
Molecular and Clinical Oncology·2015· 4 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Yingli Wu(8), Junmin Li(7), Wenbin Xu(6), Guoqiang Chen(5), Chao Wu(5), Jian‐Qing Mi(5), Jin Liang(4), Zhixiang Shen(3), Sai‐Juan Chen(3), Pradeep Puligundla(3), Xueling Gao(3), Yibin Zhou(3), Xiaochun Wan(3), Lan Xu(3), Lijuan Chen(3), Juan Du(3), Yuanfang Liu(2), Wen Wu(2), Zhenyi Wang(2), Jia Tong(2)